StockWatch
·
Pharmaceuticals
Board Meeting10 Nov 2026, 10:40 pm

Natural Capsules Board to Consider Preferential Allotment

AI Summary

Natural Capsules Ltd has announced that its Board of Directors meeting, scheduled for November 13, 2026, will consider the unaudited consolidated and standalone financial results for the quarter and half-yearly ended September 30, 2026. Additionally, the board will review the preferential allotment of 1,12,500 equity shares and 4,50,000 fully convertible equity warrants to promoter Mr. Sunil Laxminarayan Mundra. This allotment is in accordance with SEBI regulations and approvals obtained from shareholders and stock exchanges. The trading window for designated persons remains closed until 48 hours after the financial results declaration.

Key Highlights

  • Board meeting on Nov 13, 2026, to approve Q2 FY27 financial results.
  • Preferential allotment of shares and warrants to promoter Sunil Mundra.
  • Allotment follows EGM approval and stock exchange in-principle approvals.
  • Trading window closed for designated persons until results announcement.